US Stock MarketDetailed Quotes
TYPTF TRYPTAMINE THERAPEUTICS LIMITED
- 0.020
- +0.015+292.16%
15min DelayClose Oct 4 16:00 ET
23.78MMarket Cap-769P/E (TTM)
0.020High0.018Low6.10KVolume0.020Open0.005Pre Close116.00Turnover0.00%Turnover RatioLossP/E (Static)1.19BShares0.02052wk High6.67P/B23.78MFloat Cap0.00152wk Low--Dividend TTM1.19BShs Float0.020Historical High--Div YieldTTM39.22%Amplitude0.001Historical Low0.019Avg Price1Lot Size
About TRYPTAMINE THERAPEUTICS LIMITED Company
Tryptamine Therapeutics Ltd. is a clinical-stage biotechnology company, which engages in bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The company was headquartered in Kelowna, Australia.
Company Profile
SymbolTYPTF
Company NameTRYPTAMINE THERAPEUTICS LIMITED
MarketPink Market
Employees50
Fiscal Year Ends06-30
Address697 Burke Road,Suite 201
CityCamberwell
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3124
Phone61-3-9111-0026
Websitehttp://tryptherapeutics.com
Company Executives
- Name
- Position
- Salary
- Ian Edward Dixon
- Chief Executive Officer,Managing Director
- --
- Mark Davies
- Non-Executive Chairman,Non-Executive Director
- --
- Clarke Barlow
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
